-+ 0.00%
-+ 0.00%
-+ 0.00%

Envoy Medical Announces Its Pivotal Clinical Trial For Acclaim Cochlear Implant Reaches Midway Point Of Study's Full Enrollment Program

Benzinga·12/18/2025 13:12:45
Listen to the news

Envoy Medical® Inc. (NASDAQ:COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing solutions, today announced that its pivotal clinical study for the investigational fully implanted Acclaim® cochlear implant has achieved yet another milestone by reaching the midway point of the study's full enrollment target.

Despite holiday scheduling and year-end operating room constraints, enrollment is progressing at a steady pace. Sites report actively screening numerous potential candidates. Full enrollment is currently on track to be completed within the first half of Q1 2026.